Abstract:Objective To investigate the level of the thyrotropin recepter antibody (TRAb) in healthy people and patients with different types of thyroid disease,and discuss its clinical significance.Methods Recombinant human thyroid stimulating hormone receptor (TSHR)-ecd N-terminal fragment was used in N method and C-terminal fragment was used in C method as antigens respectively.The serum level of TRAb was measured in 89 healthy people and 254 patients with different types of thyroid disease respectively.The serum levels of TRAb comparison and positive rates comparison between groups were tested by analysis of variance and chi-square test respectively.Results The result of N method:the 405nm light absorption value ((x)±s) in healthy people was 0.511 ±0.135 with a cut-off value ((x)+2s) of 0.789.The positive rate was 4.5％ (4/89).The 405 nm light absorption value((x)±s) in patients with incipient Graves (diffuse toxic goiter) and Hashimoto thyroiditis with hypothyroidism was 0.95±0.30,0.61±0.22 respectively,which was higher than that in healthy people (F=2.4851 and 2.0763,both P＜0.05).The positive rate in incipient Graves disease,Graves disease with treatment,Graves disease patients in convalescence stage and Hashimoto thyroiditis with hypothyroidism was 73.2％,55.9％,32.1％,45.0％,respectively.There were significant differences between the above groups and the normal control group (x2=68.55,56.45,20.71 and 25.51,all P＜0.05).The positive rate was significantly higher in incipient Graves disease patients than Hashimoto thyroiditis with hypothyroidism patients (x2=4.63,P＜0.05).There was significant difference in the positive rate between incipient Graves disease and Graves disease patients in convalescence stage (x2=15.94,P＜0.05).The result of C method:the 405 nm light absorption value ((x)±s) in healthy people was 0.507±0.142 with a cut-off value((x)+2s) of 0.791.The positive rate was 3.4％ (3/89).The 405 nm light absorption value((x)±s) in Hashimoto thyroiditis with hypothyroidism patients and incipient Graves disease patients was 1.18±0.25,0.78±0.25,respectively,which was significantly higher than that in healthy people (F=3.8164,2.4539,P＜0.05).The positive rate in Hashimoto thyroiditis with hypothyroidism,incipient Graves disease,Graves disease with treatment,Graves disease patients in convalescence stage was 75.0％,46.3％,23.6％,16.1％,respectively.There were significant differences among the above groups and the normal control group ((x)=66.34,36.87,15.79,7.30,all P＜0.05).The positive rate was significantly higher in Hashimoto thyroiditis with hypothyroidism than other groups (x2=4.48,19.70,23.68,all P＜0.05).Conclusions The N method and C method had important significance for detecting the serum level of TRAb in Graves disease and Hashimoto thyroiditis with hypothyroidism.It may be used in clinical diagnosis,treatment and curative effect evaluation for Graves disease and Hashimoto thyroiditis with hypothyroidism.

Clinical Value of Thyroid-Stimulating Antibody Measurement Using CHO-hTSHR Cell Line

Clinical Analysis of Serum Level of the TRAb in 1 585 Normal People and Patients with Different Thyroid Diseases

Evaluation of the application of TSH receptor stimulating autoantibodies and the optimization of detection strategy in Graves’ disease

Clinical Study of Serum TRAb in 1 085 Cases of Patients with Thyroid Disease and Normal Adults

The Clinical Application of Human Serum Level of the TRAb Measured by Enzyme-Linked Immunosorbent Assay in Patients with Thyroid Diseases

The Clinical Application of A New ELISA to Detect Human Thyroid Peroxidase Autoantibody

Establishment of an Indirect ELISA Using Recombinant Human Thyroglobulin for Detecting TgAb and Its Preliminary Application

Clinical application of chemiluminescence enzyme immunoassay to quantitatively detect human thyroid peroxidase antibodies

Diagnostic value of thyroid autoantibodies in Graves' disease

Evaluation of Analytic and Clinical Performance of Two Immunoassays for Detecting Thyroid‐stimulating Receptor Antibody in the Diagnosis of Graves’ Disease

A novel human TSHR antibody ELISA using recombinant extracellular domain fragments of human TSH receptor as antigen and initial clinical evaluation

The clinical significance of TSAb in Graves' disease

Progression of assay and clinical practice of thyroid stimulating hormone receptor antibody

Study on thyrotropin receptor autoantibody in female patients with autoimmune thyroid disease determined by using recombinant human TSH receptor ectodomain

Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves’ disease and predictors of responsiveness to methimazole

Rapid Bioassay for Detection of Thyroid-Stimulating Antibodies Using Cyclic Adenosine Monophosphate-Gated Calcium Channel and Aequorin

Clinical Evaluation of an Automated TSI Bridge Immunoassay in the Diagnosis of Graves’ Disease and Its Relationship to the Degree of Hyperthyroidism

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease

Experimental study on abnormal thyroid function in patients with Hashimoto's thyroiditis caused by interference of thyroid hormone autoantibodies

The Prognostic Value of Thyroid-Stimulating Immunoglobulin in the Management of Graves’ Disease

Study on the detection value of thyroid function and related antibody in Graves disease